氯吡格雷反应性差异的分子机制研究进展

被引:5
作者
陈劲松
任艺虹
机构
[1] 中国人民解放军总医院心内科
关键词
氯吡格雷; 反应性差异; 基因多态性;
D O I
暂无
中图分类号
R543.5 [动脉疾病];
学科分类号
1002 ; 100201 ;
摘要
临床观察到有一部分患者不能从氯吡格雷治疗中获益,从而提出氯吡格雷反应性差异的问题。目前研究主要集中在基因多态性和药物的相互作用上,关于氯吡格雷反应差异的基因多态性研究可根据氯吡格雷在人体内代谢、作用过程分为吸收环节(ABCB1)、转化环节(CYP2C19、CYP3A4、CYP3A5)、作用位点环节(P2Y12)等。现就以上几个环节的最新的研究成果予以综述,力求反映相关研究的趋势与方向。
引用
收藏
页码:438 / 441
页数:4
相关论文
共 12 条
[1]   细胞色素P450 3A4 894C>T位点基因多态性与氯吡格雷抵抗的关系 [J].
韩雅玲 ;
麦晓燕 ;
李毅 ;
张效林 ;
郭亮 ;
闫承慧 .
解放军医学杂志, 2008, (08) :939-942
[2]  
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study[J] . Jean-Philippe Collet,Jean-Sébastien Hulot,Anna Pena,Eric Villard,Jean-Baptiste Esteve,Johanne Silvain,Laurent Payot,Delphine Brugier,Guillaume Cayla,Farzin Beygui,Gilbert Bensimon,Christian Funck-Brentano,Gilles Montalescot.The Lancet . 2009 (9660)
[3]   Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans [J].
Lee, Jung Myung ;
Park, Sungha ;
Shin, Dong-Jik ;
Choi, Donghoon ;
Shim, Chi Young ;
Ko, Young-Guk ;
Kim, Jung-Sun ;
Shin, Eun-Soon ;
Chang, Chong Won ;
Lee, Jong-Eun ;
Jang, Yangsoo .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (01) :46-51
[4]   Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis [J].
Giusti, Betti ;
Gori, Anna Maria ;
Marcucci, Rossella ;
Saracini, Claudia ;
Sestini, Ilaria ;
Paniccia, Rita ;
Buonamici, Piergiovanni ;
Antoniucci, David ;
Abbate, Rosanna ;
Gensini, Gian Franco .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (06) :806-811
[5]  
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study[J] . Marco Valgimigli,Gianluca Campo,Nicoletta de Cesare,Emanuele Meliga,Pascal Vranckx,Alessandro Furgieri,Dominick J. Angiolillo,Manel Sabatè,Martial Hamon,Alessandra Repetto,Sa
[6]  
Frequency of CYP3A4, CYP3A5, CYP2C9 , and CYP2C19 variant alleles in patients receiving clopidogrel that experience repeat acute coronary syndrome[J] . Marcia L. Brackbill,Robert S. Kidd,April D. Abdoo,James G. Warner,Arthur F. Harralson.Heart and Vessels . 2009 (2)
[7]  
Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents[J] . Dietmar Trenk,Willibald Hochholzer,Martin F. Fromm,Ligia-Emilia Chialda,Andreas Pahl,Christian M. Valina,Christian Stratz,Peter Schmiebusch,Hans-Peter Bestehorn,Heinz Joachim Büttner,Franz-Josef Neumann.Journal of the American College of Cardiology . 2008 (20)
[8]   Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects [J].
Kim, Kyoung-Ah ;
Park, Pil-Whan ;
Park, Ji-Young .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (06) :589-597
[9]  
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients[J] . Betti Giusti,Anna Maria Gori,Rossella Marcucci,Claudia Saracini,Ilaria Sestini,Rita Paniccia,Serafina Valente,Davide Antoniucci,Rosanna Abbate,Gian Franco Gensini.Pharmacogenetics and Genomics . 2007 (12)
[10]   Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome [J].
Cuisset, Thomas ;
Frere, Corinne ;
Quilici, Jacques ;
Morange, Pierre-Emmanuel ;
Saut, Noemie ;
Lambert, Marc ;
Camoin, Laurence ;
Vague, Irene Juhan ;
Bonnet, Jean-Louis ;
Alessi, Marie-Christine .
THROMBOSIS RESEARCH, 2007, 120 (06) :893-899